GE HealthCare Technologies (GEHC) Non-Current Assets (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Non-Current Assets came in at $26.7 billion in Q2 2026, up 10.57% YoY from $24.2 billion in Q2 2025, and little changed on a QoQ basis from $26.7 billion in Q1 2026.
GE HealthCare Technologies (GEHC) Non-Current Assets (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Non-Current Assets data on file, last reported at $26.7 billion in Q2 2026.
- Quarterly Non-Current Assets rose 10.57% year-over-year to $26.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $102.1 billion (up 67.63% YoY) and the FY2025 annual result came in at $24.4 billion, up 5.25% from the prior year.
- Non-Current Assets held at $26.7 billion in Q2 2026, from $26.7 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $26.7 billion in Q2 2026 to a low of -$9.7 billion in Q1 2025.
- A 5-year average of $21.3 billion and a median of $23.1 billion in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2025 — Non-Current Assets slumped 142.46% — and 2026, when it jumped 375.36%.
- Tracing GEHC's Non-Current Assets over 5 years: stood at $19.2 billion in 2022, then increased by 19.89% to $23.0 billion in 2023, then grew by 0.62% to $23.2 billion in 2024, then advanced by 5.25% to $24.4 billion in 2025, then climbed by 9.6% to $26.7 billion in 2026.
- The last three Non-Current Assets figures came in at $26.7 billion (Q2 2026), $26.7 billion (Q1 2026), and $24.4 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 17.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.75 Bn |
| Mar 31, 2026 | 26.70 Bn |
| Dec 31, 2025 | 24.41 Bn |
| Sep 30, 2025 | 24.23 Bn |
| Jun 30, 2025 | 24.19 Bn |
| Mar 31, 2025 | -9.70 Bn |
| Dec 31, 2024 | 23.19 Bn |
| Sep 30, 2024 | 23.22 Bn |
| Jun 30, 2024 | 23.05 Bn |
| Mar 31, 2024 | 22.84 Bn |
| Dec 31, 2023 | 23.04 Bn |
| Sep 30, 2023 | 22.91 Bn |
| Jun 30, 2023 | 23.07 Bn |
| Mar 31, 2023 | 23.03 Bn |
| Dec 31, 2022 | 19.22 Bn |